Skip to content Skip to footer

CEO, Return Health

Brief info

Psychedelic pharma executive with an established track record of founding companies (CSE TRYP), filing patents, raising capital (6 financings closed within last 12 months), running clinical trials, executing licensing contracts, obtaining FDA marketing, going public (RTO and IPO), increasing top-line sales, and reaching profitability.

Leave a comment

Tickets Are Now On Sale
Get Tickets Now